Moberg Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Net Income	-255.11	-21.09	-15.71	7.49	5.87	Upgrade
Depreciation & Amortization	0.56	2.1	2.58	2.58	2.52	Upgrade
Other Amortization	300.76	-	-	-	-	Upgrade
Stock-Based Compensation	4.72	2.31	1.46	0.63	0.95	Upgrade
Other Operating Activities	-65.36	-4.36	-3.8	-27.46	2.79	Upgrade
Change in Accounts Receivable	-0.71	0.42	-0.21	6.84	-2.79	Upgrade
Change in Inventory	2.82	-7.12	-	-	-	Upgrade
Change in Other Net Operating Assets	-4.14	-5.46	-1.16	-4.99	-18.43	Upgrade
Operating Cash Flow	-16.47	-33.21	-16.84	-15.3	-10.41	Upgrade
Cash Acquisitions	-	-	-	-10	-2.51	Upgrade
Sale (Purchase) of Intangibles	-73.55	-124.12	-68.07	-31.31	-41.42	Upgrade
Investing Cash Flow	-73.55	-124.12	-68.07	-41.31	-43.93	Upgrade
Long-Term Debt Repaid	-1.39	-2.43	-1.87	-3.46	-	Upgrade
Total Debt Repaid	-1.39	-2.43	-1.87	-3.46	-18.17	Upgrade
Net Debt Issued (Repaid)	-1.39	-2.43	-1.87	-3.46	-18.17	Upgrade
Issuance of Common Stock	324.15	100.64	109.68	133.44	37.54	Upgrade
Repurchase of Common Stock	-	-0.19	-	-	-558.27	Upgrade
Other Financing Activities	-	-5.7	-	-	-	Upgrade
Financing Cash Flow	322.76	92.33	107.81	129.97	-538.89	Upgrade
Net Cash Flow	232.73	-65	22.9	73.37	-593.23	Upgrade
Free Cash Flow	-16.47	-33.21	-16.84	-15.3	-10.41	Upgrade
Free Cash Flow Margin	-167.87%	-	-8136.23%	-	-30.93%	Upgrade
Free Cash Flow Per Share	-0.44	-2.09	-2.22	-3.55	-5.50	Upgrade
Cash Interest Paid	-	0.26	0.07	0.24	2.07	Upgrade
Levered Free Cash Flow	27.29	-149.44	-65.28	40.32	-	Upgrade
Unlevered Free Cash Flow	27.43	-149.28	-65.24	40.4	-	Upgrade
Change in Net Working Capital	2.03	12.13	-11.62	-80.83	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.